First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2003-04-25 10:53:02Open Document File Size: 208,41 KBShare Result on FacebookCityCincinnati / Philadelphia / Portland / Washington / Boston / Cambridge / /CompanyNovartis / Amgen / GlaxoSmithKline / Merck / The New York Times / The New England Journal / Burroughs Wellcome Co. / Pfizer / Public Citizen / Dole / /ContinentAmerica / /CountryIsrael / United States / Columbia / /CurrencyUSD / /EventFDA Phase / Person Communication and Meetings / Patent Issuance / /FacilityColumbia University / Duke University / University of Rochester Graduate School / Oregon Health Sciences University / Tufts Center / University of Chicago / Tufts University / /IndustryTermtreatment of kidney failure / brand-name pharmaceuticals / pharmaceutical industry / biotechnology industries / generic product / pharmaceutical innovation / chemical entities / manufacturing / advertising enterprise / pharmaceutical accounts / debatable accounting theory / biotechnology / profitable new products / definitive chemical identification / cancer treatment / treatment of other cancers / insurance plans / marketed drug products / pharmaceutical / treatment of a type of blood cancer / individual pharmaceutical firms / consumer watch / telephone conversations / pharmaceutical giant / treatment of AIDS / advertising money / public relations / treatment for cancer / pharmaceutical firms / /MedicalConditionarthritis / chronic kidney disease / blood cancer / leukemia / cancer / allergy / kidney failure / diseases / AIDS / high blood pressure / depression / experimental viral infections / severe anemia / hay fever / HIV infection / cancers / acute diseases / disease / erectile dysfunction / heart failure / chronic myeloid leukemia / anemia / /MedicalTreatmentcombination drug therapy / drug therapy / /OrganizationColumbia University / Oregon Health Sciences University / Department of Economics / U.S. government / state medical society / Michigan Cancer Foundation / office of the Inspector General / University of Rochester Graduate School / Medicare / Duke University / Association of American Medical Colleges / Pharmaceutical Research and Manufacturers of America / FDA / Securities and Exchange Commission / Harvard Medical School / National Institute of Health / Food and Drug Administration / MIT / Tufts University / national professional organization / Congress / American Medical Student Association / the University of Chicago / American Medical Association / Department of Health and Human Services / Tufts Center for the Study of Drug Development / Office for Technology Assessment / /PersonMarcia Angell / KEN ORVIDAS / Joseph DiMasi / Brian J. Druker / Raymond V. Gilmartin / Bill Moyers / Arnold S. Relman / /Positionphysician / professor emeritus / influential chairman and CEO / senior author / senior lecturer / speaker / consultant / scientist / candidate drug / editor-in-chief / clinical research physician / professor emeritus of medicine and social medicine / /ProductGleevec / Retrovir / Capoten / Zovirax / Zantac / Zidovudine / Prozac / Vasotec / newly approved drug / Other Drug / drug / /ProvinceOrStateMassachusetts / /PublishedMediumThe New York Times / THE NEW REPUBLIC / The New England Journal of Medicine / /Technologybiotechnology / Drug Development / /SocialTag |